Cyclooxygenase blockade elevates leukotriene E4 production during acute anaphylaxis in sheep. 1986

D R Robinson, and M Skoskiewicz, and K J Bloch, and G Castorena, and E Hayes, and E Lowenstein, and C Melvin, and F Michelassi, and W M Zapol

We examined changes in the levels of eicosanoids in blood and pulmonary lymph of anesthetized sheep undergoing acute anaphylaxis. Within 1-3 min of intravenous antigenic challenge of previously sensitized sheep, there were approximately 7-30-fold elevations in mean arterial plasma levels of thromboxane B2 and 6-ketoprostaglandin F1 alpha, respectively, as measured by RIA. Negligible changes in levels of these cyclooxygenase products were found in both nonsensitized sheep and in sensitized sheep treated with indomethacin before antigenic challenge. In contrast, no changes in levels of sulfidopeptide leukotrienes (SPLT) in pulmonary lymph were detectable by RIA during anaphylaxis in sensitized or nonsensitized sheep, but levels of SPLT in indomethacin-treated sensitized sheep increased more than fivefold above levels in lymph from both other groups of animals. The immunoreactive SPLT in lymph from indomethacin-treated sheep was accounted for as LTE4, as demonstrated by mobility on HPLC and absorbance at 280 nm. These results support the possibility that certain undesirable effects of nonsteroidal antiinflammatory drugs, such as cardiopulmonary reactions in aspirin-sensitive individuals, and impaired renal and cardiac function during therapy with these drugs, may be related in part to augmented synthesis of the 5-lipoxygenase pathway products, especially those of the sulfidopeptide class. Increased LT production could also limit the antiinflammatory effectiveness of these drugs in many disease states.

UI MeSH Term Description Entries
D007213 Indomethacin A non-steroidal anti-inflammatory agent (NSAID) that inhibits CYCLOOXYGENASE, which is necessary for the formation of PROSTAGLANDINS and other AUTACOIDS. It also inhibits the motility of POLYMORPHONUCLEAR LEUKOCYTES. Amuno,Indocid,Indocin,Indomet 140,Indometacin,Indomethacin Hydrochloride,Metindol,Osmosin
D008084 Lipoxygenase An enzyme of the oxidoreductase class primarily found in PLANTS. It catalyzes reactions between linoleate and other fatty acids and oxygen to form hydroperoxy-fatty acid derivatives. Lipoxidase,Linoleate-Oxygen Oxidoreductase,Lipoxygenase-1,Lipoxygenase-2,Linoleate Oxygen Oxidoreductase,Lipoxygenase 1,Lipoxygenase 2,Oxidoreductase, Linoleate-Oxygen
D008168 Lung Either of the pair of organs occupying the cavity of the thorax that effect the aeration of the blood. Lungs
D008196 Lymph The interstitial fluid that is in the LYMPHATIC SYSTEM. Lymphs
D011451 Prostaglandin-Endoperoxide Synthases Enzyme complexes that catalyze the formation of PROSTAGLANDINS from the appropriate unsaturated FATTY ACIDS, molecular OXYGEN, and a reduced acceptor. Fatty Acid Cyclo-Oxygenase,PGH Synthase,Prostaglandin H Synthase,Prostaglandin Synthase,Prostaglandin-Endoperoxide Synthase,Arachidonic Acid Cyclooxygenase,Cyclo-Oxygenase,Cyclooxygenase,Cyclooxygenases,Hydroperoxide Cyclase,PGH2 Synthetase,Prostaglandin Cyclo-Oxygenase,Prostaglandin Cyclooxygenase,Prostaglandin Endoperoxide Synthetase,Prostaglandin G-H Synthase,Prostaglandin H2 Synthetase,Prostaglandin Synthetase,Cyclase, Hydroperoxide,Cyclo Oxygenase,Cyclo-Oxygenase, Fatty Acid,Cyclo-Oxygenase, Prostaglandin,Cyclooxygenase, Arachidonic Acid,Cyclooxygenase, Prostaglandin,Endoperoxide Synthetase, Prostaglandin,Fatty Acid Cyclo Oxygenase,G-H Synthase, Prostaglandin,Prostaglandin Cyclo Oxygenase,Prostaglandin Endoperoxide Synthases,Prostaglandin G H Synthase,Synthase, PGH,Synthase, Prostaglandin,Synthase, Prostaglandin G-H,Synthase, Prostaglandin H,Synthase, Prostaglandin-Endoperoxide,Synthases, Prostaglandin-Endoperoxide,Synthetase, PGH2,Synthetase, Prostaglandin,Synthetase, Prostaglandin Endoperoxide,Synthetase, Prostaglandin H2
D000208 Acute Disease Disease having a short and relatively severe course. Acute Diseases,Disease, Acute,Diseases, Acute
D000707 Anaphylaxis An acute hypersensitivity reaction due to exposure to a previously encountered ANTIGEN. The reaction may include rapidly progressing URTICARIA, respiratory distress, vascular collapse, systemic SHOCK, and death. Anaphylactic Reaction,Anaphylactoid Reaction,Anaphylactoid Shock,Shock, Anaphylactic,Anaphylactic Reactions,Anaphylactic Shock,Anaphylactoid Reactions,Reaction, Anaphylactic,Reaction, Anaphylactoid,Shock, Anaphylactoid
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000893 Anti-Inflammatory Agents Substances that reduce or suppress INFLAMMATION. Anti-Inflammatory Agent,Antiinflammatory Agent,Agents, Anti-Inflammatory,Agents, Antiinflammatory,Anti-Inflammatories,Antiinflammatories,Antiinflammatory Agents,Agent, Anti-Inflammatory,Agent, Antiinflammatory,Agents, Anti Inflammatory,Anti Inflammatories,Anti Inflammatory Agent,Anti Inflammatory Agents
D001091 Arachidonate Lipoxygenases Enzymes catalyzing the oxidation of arachidonic acid to hydroperoxyarachidonates. These products are then rapidly converted by a peroxidase to hydroxyeicosatetraenoic acids. The positional specificity of the enzyme reaction varies from tissue to tissue. The final lipoxygenase pathway leads to the leukotrienes. EC 1.13.11.- . Arachidonic Acid Lipoxygenase,Lipoxygenase, Arachidonic Acid,Lipoxygenases, Arachidonate

Related Publications

D R Robinson, and M Skoskiewicz, and K J Bloch, and G Castorena, and E Hayes, and E Lowenstein, and C Melvin, and F Michelassi, and W M Zapol
April 1990, Journal of applied physiology (Bethesda, Md. : 1985),
D R Robinson, and M Skoskiewicz, and K J Bloch, and G Castorena, and E Hayes, and E Lowenstein, and C Melvin, and F Michelassi, and W M Zapol
April 2008, Allergy,
D R Robinson, and M Skoskiewicz, and K J Bloch, and G Castorena, and E Hayes, and E Lowenstein, and C Melvin, and F Michelassi, and W M Zapol
November 2007, Immunology and allergy clinics of North America,
D R Robinson, and M Skoskiewicz, and K J Bloch, and G Castorena, and E Hayes, and E Lowenstein, and C Melvin, and F Michelassi, and W M Zapol
November 1990, Circulatory shock,
D R Robinson, and M Skoskiewicz, and K J Bloch, and G Castorena, and E Hayes, and E Lowenstein, and C Melvin, and F Michelassi, and W M Zapol
February 1994, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology,
D R Robinson, and M Skoskiewicz, and K J Bloch, and G Castorena, and E Hayes, and E Lowenstein, and C Melvin, and F Michelassi, and W M Zapol
January 1987, Progress in clinical and biological research,
D R Robinson, and M Skoskiewicz, and K J Bloch, and G Castorena, and E Hayes, and E Lowenstein, and C Melvin, and F Michelassi, and W M Zapol
February 1986, Archives of biochemistry and biophysics,
D R Robinson, and M Skoskiewicz, and K J Bloch, and G Castorena, and E Hayes, and E Lowenstein, and C Melvin, and F Michelassi, and W M Zapol
January 1992, The Journal of laboratory and clinical medicine,
D R Robinson, and M Skoskiewicz, and K J Bloch, and G Castorena, and E Hayes, and E Lowenstein, and C Melvin, and F Michelassi, and W M Zapol
January 2014, International journal of general medicine,
D R Robinson, and M Skoskiewicz, and K J Bloch, and G Castorena, and E Hayes, and E Lowenstein, and C Melvin, and F Michelassi, and W M Zapol
January 2003, The European respiratory journal,
Copied contents to your clipboard!